MeMed Diagnostics Ltd (MeMed) is a developer of diagnostic solutions for inflammatory and infectious diseases. The company’s products include ImmunoXpert which is an in-vitro diagnostic test used for diagnosing the difference between bacterial and viral infections. It provides ImmunoPoC, a hand-held instrument used for the diagnosis of bacterial versus viral infections. MeMed offers services in varied fields including molecular immunology, clinical infectious diseases, informatics and in vitro diagnostics. The company uses its technology to discover, develop and validate novel diagnostic solutions. It partners with various academic, clinical and commercial partners. The company operates through its manufacturing and research and development facilities in Israel. MeMed is headquartered in Tirat Carmel, Israel.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company MeMed Diagnostics Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- MeMed Diagnostics Ltd Company Overview
- MeMed Diagnostics Ltd Company Snapshot
- MeMed Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview
- MeMed Diagnostics Ltd - Pipeline Analysis Overview
- MeMed Diagnostics Ltd - Key Facts
- MeMed Diagnostics Ltd - Major Products and Services
- MeMed Diagnostics Ltd Pipeline Products by Development Stage
- MeMed Diagnostics Ltd Pipeline Products Overview
- Diagnostic Test - COVID-19
- Diagnostic Test - COVID-19 Product Overview
- ImmunoPoC
- ImmunoPoC Product Overview
- MeMed Alert
- MeMed Alert Product Overview
- MeMed COVID-19 Severity Test
- MeMed COVID-19 Severity Test Product Overview
- MeMed ImmnuoRNA
- MeMed ImmnuoRNA Product Overview
- MeMed Neo
- MeMed Neo Product Overview
- MeMed Sepsis
- MeMed Sepsis Product Overview
- MeMed Ultra Flu
- MeMed Ultra Flu Product Overview
- MeMed Diagnostics Ltd - Key Competitors
- MeMed Diagnostics Ltd - Key Employees
- MeMed Diagnostics Ltd - Locations And Subsidiaries
- Head Office
- Recent Developments
- MeMed Diagnostics Ltd, Recent Developments
- Nov 06, 2023: MeMed Bolsters Leadership Team With Appointment of Ori Hadomi as Chairman and Peter Scheu as President of MeMed US
- Oct 24, 2023: MeMed awarded US BARDA Contract to Demonstrate Clinical Utility of the FDA-Cleared MeMed BV Test for Distinguishing Bacterial From Viral infections
- Jul 20, 2023: FDA grants 510(k) clearance for MeMed BV test on whole blood samples
- Jul 19, 2023: MeMed: FDA Clears Pioneering MeMed BV Test Direct From Whole Blood Allowing Faster Time To Result And Broader Patient Access When Distinguishing Bacterial From Viral Infections
- Jul 12, 2023: MeMed Diagnostics Receives Additional 510(k) Clearance for MeMed BV
- May 25, 2023: Nutex Health announces agreement with MeMed to adopt pioneering MeMed BV test across its network of 19 sites
- Apr 18, 2023: Clinical data validate pioneering MeMed BV technology improves diagnosis of pediatric patients with fever in the Emergency Department
- Apr 12, 2023: MeMed Diagnostics receives additional 510(k) clearance for MeMed BV
- Jan 31, 2023: Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Bacterial and Viral Infections
- Dec 22, 2022: Tulsa ER & Hospital adopts trailblazing MeMed BV Test
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- MeMed Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview
- MeMed Diagnostics Ltd Pipeline Products by Equipment Type
- MeMed Diagnostics Ltd Pipeline Products by Indication
- MeMed Diagnostics Ltd, Key Facts
- MeMed Diagnostics Ltd, Major Products and Services
- MeMed Diagnostics Ltd Number of Pipeline Products by Development Stage
- MeMed Diagnostics Ltd Pipeline Products Summary by Development Stage
- Diagnostic Test - COVID-19 - Product Status
- Diagnostic Test - COVID-19 - Product Description
- ImmunoPoC - Product Status
- ImmunoPoC - Product Description
- MeMed Alert - Product Status
- MeMed Alert - Product Description
- MeMed COVID-19 Severity Test - Product Status
- MeMed COVID-19 Severity Test - Product Description
- MeMed ImmnuoRNA - Product Status
- MeMed ImmnuoRNA - Product Description
- MeMed Neo - Product Status
- MeMed Neo - Product Description
- MeMed Sepsis - Product Status
- MeMed Sepsis - Product Description
- MeMed Ultra Flu - Product Status
- MeMed Ultra Flu - Product Description
- MeMed Diagnostics Ltd, Key Employees
- Glossary
- MeMed Diagnostics Ltd Pipeline Products by Equipment Type
- MeMed Diagnostics Ltd Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Trima Pharmaceutical Products Maabarot Ltd
- Perrigo Israel Pharmaceuticals Ltd
- JPMed Ltd
